Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.

Managing Upper and Lower Airway Diseases: The Role of Epithelial-Driven Inflammation This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.

Synchrony Medical, a medical technology company dedicated to advancing respiratory care, today announced that it has received ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

The prevalence of respiratory and chronic obstructive pulmonary disease (COPD) are the main factors driving the rise in ...

Disease of small airways may be common to various chronic obstructive lung diseases. Because R p is normally so small, there may be considerable obstruction in peripheral airways that would affect ...

Loss of a key immune protein disrupted cell signaling and defense, revealing a novel driver of chronic airway inflammation in ...

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...

Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

As the number of people with allergies grows worldwide, scientists are trying to work out precisely how and why these conditions—such as asthma and eczema—develop.